NEW

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

NEC Corporation has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan and is expected to soon be available in Europe.

PATHOGON UV Disinfection System

The PATHOGON UV Disinfection System from STERIS provides assurance and sense of security that the room has been terminally cleaned to the highest standard of care and is ready for the next case.  PATHOGON UV reduces the risk of infection and cross contamination in the OR for patients and operating room staff. It delivers a calculated dose of germicidal UV-C energy in as little as 4 minutes to kill pathogens on environmental surfaces and has be shown to deliver a 3-4 log reduction of C-Diff spores and 5-7 log reduction of bacteria and viruses. The system employs a wireless controller that makes it easy to initiate and monitor cycles from outside the room and automatically tracks cycle data and usage. It uses redundant heat/motion sensors to protect staff against accidental exposure.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X